NEW YORK (GenomeWeb News) – Vermillion has appointed Donald Munroe as chief scientific officer and vice president of research and development. Eric Fung, the company's former chief scientific officer, will now serve as chief medical officer. Munroe was previously vice president of immunoassay research and development at Beckman Coulter. Before that he held several management roles at Invitrogen and worked in pharmaceutical discovery research experience at the RW Johnson Pharmaceutical Research Institute.
Expression Analysis has hired Tyler Aldredge as vice president of laboratory operations. Aldredge was most recently director of laboratory operations at Genzyme Genetics. Prior to that, he held positions at the Broad Institute, the Harvard University Center for Genomic Research, Sanofi, Codon Devices, and Genome Therapeutics.
Eagle Genomics co-founder and founding CEO Abel Ureta-Vidal has stepped down and will be replaced by David Flanders, the former head of StemCells' UK operations. Ureta-Vidal will become the firm's full-time chief operating officer. Flanders formerly was head of basic technologies at the German bioinformatics firm Lion Bioscience.
Frank McCormick has joined the cancer biomarker testing firm PrognosDx Health as an ad-hoc adviser to the company. McCormick is associate dean of the University of California at San Francisco's School of Medicine and director of the Helen Diller Family Comprehensive Cancer Center. He also is president-elect of the American Association for Cancer Research.
The Massachusetts Life Sciences Center has named Dalia Cohen to serve on its scientific advisory board. Cohen is currently is chief scientific officer at Asterand and formerly she was global head of functional genomics at the Novartis Institute for Biomedical Research and CSO for Rosetta Genomics.
In vitro diagnostics company DiaDexus said this week that it has added Brian Ward as its new CEO and Michael Richer as its new chief business officer, and that current executive VP and COO Bernard Alfano will leave the company. Interim CEO Jim Panek will remain with the South San Francisco-based firm as a member of its board of directors.
Indiana School of Medicine researcher and pediatrician Jamie Renbarger was named a recipient of a Presidential Early Career Award for Scientists and Engineers by President Barack Obama this week. Renbarger, who is associate director of the Indiana Institute for Personalized Medicine and a member of the Indiana University Melvin and Bren Simon Cancer Center, was chosen for the award for pharmacogenomics research focused on optimizing the use of vincristine in treating children with cancer.
Protein analysis firm BioScale has appointed Riccardo Pigliucci to serve on its board of directors. Pigliucci formerly was president, COO, and member of the board at PerkinElmer, CEO of Life Sciences International, and CEO of Discovery Partners International. He most recently was lead director on the board of Dionex.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.